SG11202012496XA - Promoting immune responses - Google Patents
Promoting immune responsesInfo
- Publication number
- SG11202012496XA SG11202012496XA SG11202012496XA SG11202012496XA SG11202012496XA SG 11202012496X A SG11202012496X A SG 11202012496XA SG 11202012496X A SG11202012496X A SG 11202012496XA SG 11202012496X A SG11202012496X A SG 11202012496XA SG 11202012496X A SG11202012496X A SG 11202012496XA
- Authority
- SG
- Singapore
- Prior art keywords
- immune responses
- promoting immune
- promoting
- responses
- immune
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2018091177 | 2018-06-14 | ||
PCT/CN2019/090647 WO2019238024A1 (en) | 2018-06-14 | 2019-06-11 | Promoting immune responses |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202012496XA true SG11202012496XA (en) | 2021-01-28 |
Family
ID=68842704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202012496XA SG11202012496XA (en) | 2018-06-14 | 2019-06-11 | Promoting immune responses |
Country Status (9)
Country | Link |
---|---|
US (1) | US11229707B2 (en) |
EP (1) | EP3752163A4 (en) |
JP (1) | JP2021527133A (en) |
KR (1) | KR20210020104A (en) |
CN (1) | CN111971049A (en) |
AU (1) | AU2019284192A1 (en) |
CA (1) | CA3103724A1 (en) |
SG (1) | SG11202012496XA (en) |
WO (1) | WO2019238024A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022127914A1 (en) | 2020-12-18 | 2022-06-23 | Pyrotech (Beijing) Biotechnology Co., Ltd. | Nucleoside-thiodiphosphate-heptose compounds for treating conditions associated with alpk1 activity |
WO2023051675A1 (en) | 2021-09-30 | 2023-04-06 | Pyrotech (Beijing) Biotechnology Co., Ltd. | Nucleoside-diphosphate-heptose compounds for treating conditions associated with alpk1 activity |
CN117517657B (en) * | 2024-01-08 | 2024-04-09 | 中国农业科学院北京畜牧兽医研究所 | Application of LNX1 gene or protein in regulation of avian innate immune response |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6044499A (en) * | 1998-09-25 | 2000-04-17 | Diagnon Corporation | High throughput assay method for enzymes which metabolically hydrolyze nucleoside triphosphates and an assay system therefor |
JPWO2007119815A1 (en) * | 2006-04-14 | 2009-08-27 | 協和発酵キリン株式会社 | Toll-like receptor 9 agonist |
EP3204014B1 (en) * | 2014-10-10 | 2020-07-01 | The Governing Council of the University of Toronto | Methods of modulating immune system responses |
JP2020507616A (en) * | 2017-02-17 | 2020-03-12 | アイビタ バイオメディカル インコーポレイテッド | Methods of enhancing tumor immunogenicity using modified tumor cells and modified dendritic cells and compositions of autologous cancer immunotherapy products |
JP2021500394A (en) * | 2017-10-27 | 2021-01-07 | シャンハイ・ヤオ・ユアン・バイオテクノロジー・カンパニー・リミテッド | Compositions and Methods for Modulating an Immune Response by Activating α-Protein Kinase 1 |
-
2019
- 2019-06-11 SG SG11202012496XA patent/SG11202012496XA/en unknown
- 2019-06-11 CN CN201980025130.1A patent/CN111971049A/en active Pending
- 2019-06-11 JP JP2021518839A patent/JP2021527133A/en active Pending
- 2019-06-11 CA CA3103724A patent/CA3103724A1/en not_active Abandoned
- 2019-06-11 WO PCT/CN2019/090647 patent/WO2019238024A1/en unknown
- 2019-06-11 EP EP19818829.4A patent/EP3752163A4/en not_active Withdrawn
- 2019-06-11 KR KR1020217000953A patent/KR20210020104A/en unknown
- 2019-06-11 AU AU2019284192A patent/AU2019284192A1/en not_active Abandoned
-
2020
- 2020-09-15 US US17/022,073 patent/US11229707B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US11229707B2 (en) | 2022-01-25 |
AU2019284192A1 (en) | 2021-01-28 |
US20200405869A1 (en) | 2020-12-31 |
KR20210020104A (en) | 2021-02-23 |
EP3752163A4 (en) | 2021-04-07 |
CN111971049A (en) | 2020-11-20 |
CA3103724A1 (en) | 2019-12-19 |
JP2021527133A (en) | 2021-10-11 |
EP3752163A1 (en) | 2020-12-23 |
WO2019238024A1 (en) | 2019-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA186068S (en) | Food preparation device | |
CA185923S (en) | Toaster | |
IL278864A (en) | Shared antigens | |
IL264557A (en) | Biomaterials for modulating immune responses | |
AU201815480S (en) | Blender | |
CA184989S (en) | Uroflowmeter | |
PL3622862T3 (en) | Playpen | |
ZA201903369B (en) | Nutcracker | |
SG11202012496XA (en) | Promoting immune responses | |
DK3571208T3 (en) | IMMUNE PROTEASOMINHIBITORS | |
GB201918689D0 (en) | n | |
GB2567755B (en) | Cooker | |
PL3807576T3 (en) | Cooking device | |
PL3518617T3 (en) | Cooking device | |
GB201805799D0 (en) | b | |
CA186910S (en) | Broiler | |
AU201811706S (en) | Egg poachers | |
GB2567330B (en) | Cooker | |
CA185924S (en) | Toaster | |
ZA202100026B (en) | Complex for enhancing immune response | |
CA185309S (en) | Armchair | |
ZAA201801262S (en) | Toaster | |
GB201901594D0 (en) | Cooking device | |
PL3732397T3 (en) | Cooker | |
GB201814379D0 (en) | Concept four |